...
首页> 外文期刊>Molecular Metabolism >Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis
【24h】

Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis

机译:特异性肝细胞特异性PKCβ缺乏可防止高脂肪饮食诱导的非酒精性肝脏脂肪变性

获取原文
           

摘要

Objective Nonalcoholic hepatic steatosis, also known as fatty liver, is a uniform response of the liver to hyperlipidic-hypercaloric diet intake. However, the post-ingestive signals and mechanistic processes driving hepatic steatosis are not well understood. Emerging data demonstrate that protein kinase C beta (PKCβ), a lipid-sensitive kinase, plays a critical role in energy metabolism and adaptation to environmental and nutritional stimuli. Despite its powerful effect on glucose and lipid metabolism, knowledge of the physiological roles of hepatic PKCβ in energy homeostasis is limited. Methods The floxed-PKCβ and hepatocyte-specific PKCβ-deficient mouse models were generated to study the in?vivo role of hepatocyte PKCβ on diet-induced hepatic steatosis, lipid metabolism, and mitochondrial function. Results We report that hepatocyte-specific PKCβ deficiency protects mice from development of hepatic steatosis induced by high-fat diet, without affecting body weight gain. This protection is associated with attenuation of SREBP-1c transactivation and improved hepatic mitochondrial respiratory chain. Lipidomic analysis identified significant increases in the critical mitochondrial inner membrane lipid, cardiolipin, in PKCβ-deficient livers compared to control. Moreover, hepatocyte PKCβ deficiency had no significant effect on either hepatic or whole-body insulin sensitivity supporting dissociation between hepatic steatosis and insulin resistance. Conclusions The above data indicate that hepatocyte PKCβ is a key focus of dietary lipid perception and is essential for efficient storage of dietary lipids in liver largely through coordinating energy utilization and lipogenesis during post-prandial period. These results highlight the importance of hepatic PKCβ as a drug target for obesity-associated nonalcoholic hepatic steatosis.
机译:客观的非酒精性肝脏脂肪变性,也称为脂肪肝,是肝脏均匀反应,对高脂酸性高型饮食摄入量。然而,驾驶肝脏脂肪变性的摄入后信号和机械过程尚不清楚。新兴数据表明,蛋白激酶Cβ(PKCβ),脂质敏感激酶,在能量代谢和对环境和营养刺激的适应中起着关键作用。尽管其对葡萄糖和脂质代谢的强烈影响,但肝PKCβ在能量稳态中的生理作用知识有限。方法生成氟纤维-PKCβ和肝细胞特异性PKCβ缺乏小鼠模型研究肝细胞PKCβ对肝细胞患者诱导的肝脏脂肪变性,脂质代谢和线粒体功能的体内作用。结果我们报告说,肝细胞特异性PKCβ缺乏保护小鼠免受高脂饮食引起的肝脏脂肪变性的发展,而不会影响体重增加。这种保护与Srebp-1C反式激活的衰减和改善的肝线粒体呼吸链有关。与对照相比,脂质化学分析鉴定了临界线粒体内膜脂,心肌脂蛋白的临界线粒体内膜脂质,心肌脂蛋白。此外,肝细胞PKCβ缺乏对肝脏脂肪变性和胰岛素抗性之间的肝癌或全身胰岛素敏感性没有显着影响。结论上述数据表明,肝细胞PKCβ是膳食脂质感知的关键焦点,并且主要通过协调折补期间的能量利用和脂肪生成,高效地储存肝脏中的膳食脂质。这些结果突出了肝PKCβ作为肥胖相关的非酒精性肝脏脂肪变性的药物靶标的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号